Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details 2)

v3.21.1
STOCKHOLDERS' EQUITY (Details 2)
3 Months Ended
Mar. 31, 2021
$ / shares
shares
Equity [Abstract]  
Balance outstanding at the beginning of the period (in shares) | shares 2,870
Balance at the beginning of the period (in dollars per share) | $ / shares $ 20.36
Forfeited (in shares) | shares (10)
Forfeited (in dollars per share) | $ / shares $ 22.44
Vested (in shares) | shares (774)
Vested (in dollars per share) | $ / shares $ 16.16
Granted (in shares) | shares 778
Granted (in dollars per share) | $ / shares $ 37.04
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance | shares 2,864
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 26.02